T
TrueMed
TrueMed enables health and wellness merchants to tap into the $140 billion in customer HSA and FSA funds
About TrueMed
TrueMed is a pioneering startup that operates in the health and wellness market. The company provides a unique payment integration solution that allows customers to use their Health Savings Account (HSA) and Flexible Spending Account (FSA) funds to purchase health-promoting products and services. These accounts are pre-tax savings accounts that individuals can use to pay for qualified medical expenses. TrueMed's platform enables merchants to tap into the $140 billion pool of customer HSA and FSA funds, thereby expanding their customer base and increasing sales.
TrueMed primarily serves health and wellness merchants who sell products such as healthy food, supplements, exercise equipment, and other health-related items. By integrating TrueMed's payment option into their checkout flow, these merchants can offer their customers a convenient way to use their HSA and FSA funds directly at the point of sale. This not only simplifies the purchasing process for customers but also encourages them to invest in products that promote better health and well-being.
The business model of TrueMed revolves around providing a seamless payment integration service to merchants. The company likely earns revenue through transaction fees or subscription fees charged to merchants who use their platform. By facilitating the use of HSA and FSA funds, TrueMed adds value to both merchants and customers, creating a win-win situation.
In summary, TrueMed is revolutionizing the way health and wellness products are purchased by enabling the use of HSA and FSA funds. The company operates in the health and wellness market, serves merchants selling health-promoting products, and makes money through transaction or subscription fees.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2025 | $34M | $136M | BoxGroup · Trust Ventures · Long Journey Ventures · Andreessen Horowitz | ↗ |
| SEEDEquity / VC | Sep 2023 | $3.5M | $14M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for TrueMed is 960K monthly website visits, up 17.1% over the last three months. TrueMed's team grew 45.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Andreessen Horowitz
BoxGroup
Trust Ventures
Long Journey Ventures
Bessemer Venture Partners
Other known investors2 additional known investors
Learn Capital
Weekend Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about TrueMed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TrueMed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







